Takashi Kishimoto compensation by year
Cartesian Therapeutics Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2021 |
|---|---|---|
| Salary | $386,703 | $399,798 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $214,133 |
| Option awards | $237,063 | $526,588 |
| Non-equity incentive | $177,949 | $160,000 |
| Pension and deferred compensation | $0 | $0 |
| All other | $5,618 | $6,156 |
| Total | $807,333 | $1,306,675 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cartesian Therapeutics, Inc. DEF 14A filed May 3, 2022, accession 0001453687-22-000071, and prior-year filings.
How this page was built: the Cartesian Therapeutics, Inc. filed document, accession 0001453687-22-000071. Every figure is read from that document and cited to the page and table it appears in. Filed May 3, 2022.
Equity holdings
unvested awards at FY2021 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 38,000 | $123,880 | — |
| Option | 27,082 | — | $2.60 |
| Option | 230,000 | — | $2.99 |
| Option | 72,916 | — | $2.30 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Cartesian Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.
Cartesian Therapeutics’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $3,671,395 |
| Kevin Tan | Chief Financial Officer | $2,601,622 |
| Peter Traber | Chief Medical Officer | $1,600,685 |
| Takashi Kishimoto · this page | Chief Scientific Officer | $1,306,675 |
| Lloyd Johnston | Chief Operations Officer | $1,304,845 |
| Bradford Dahms | Chief Financial Officer | $868,053 |
| Ann Donohue | VP, Finance and Corporate Controller, Principal Financial and Accounting Officer | $361,493 |
The full Cartesian Therapeutics compensation record
free company briefThis page is one person within Cartesian Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Cartesian Therapeutics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cartesian Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.